Specialty Pharmacy Oncology Revenue Increasing at Expense of Buy and Bill Usage

$99.00

Specialty Pharmacy Oncology Revenue Increasing at Expense of Buy and Bill Usage. The term “Buy and Bill” refers to the process of physician management of certain medicines, primarily specialty medicines or drugs that require injection or infusion. AMI reported in early 2018 that the Buy and Bill Process Will Continue to Diminish.

AMI’s new report,Specialty Pharmacy Oncology Increasing at Expense of Buy and Bill Usage, builds upon our February 2018 report and focuses on the increasingly important role that specialty pharmacies are playing in the dispensing of oncology drugs, at the expense of Buy and Bill usage.